6533b871fe1ef96bd12d2216

RESEARCH PRODUCT

Recombinant human erythropoietin (rhEpo) enhances recovery from cisplatin (CDDP) - induced anemia in golden syrian hamsters

Roberto ValenzaSergio PalmeriVittorio GebbiaLuciano Rausa

subject

PharmacologyCisplatinAnemiabusiness.industryPharmacologymedicine.diseaselaw.inventionlawErythropoietinRecombinant DNAmedicinebusinessSyrian hamstersmedicine.drughttps://doi.org/10.1016/s1043-6618(09)80257-0